Marc Blaustein
CIK 1880032 · Chief Operating Officer · last filed 2023-02-23
Marc Blaustein is a Chief Operating Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $1.8K of FNCH on Feb 23, 2023. Across all open-market trades the lifetime net is −$6.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
5
-$6.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Chief Operating Officer | 27,995 | $7.30 | $204.4K | -$6.8K | 5 | 2023-02-23 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-23 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Sell (S) | −4,619 | -$1.8K | EDGAR |
| 2022-10-25 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Sell (S) | −3,636 | -$5.1K | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2022-02-28 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-10 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |